Patients who suffer a first broken bone due to underlying osteoporosis are at two- to threefold risk of subsequent fractures—which can lead to a host of serious outcomes such as pain, disability, loss of quality of life ...
Apr 25, 2017
1
0
A new Position Statement, jointly published by seven international and European organizations, identifies fracture-related risk factors in patients treated by aromatase-inhibitors (AI) and outlines key management strategies ...
Apr 25, 2017
0
3
More research is needed to determine the benefits and harms of osteoporosis medications on bone mineral density (BMD), fracture risk, and safety among patients with chronic kidney disease (CKD). This is important because ...
Apr 10, 2017
0
0
(HealthDay)—For patients with type 2 diabetes mellitus (T2DM), long-term use of dipeptidyl peptidase-4 inhibitors (DPP4-Is) is not associated with fracture risk, according to a study published online Dec. 10 in Diabetes, ...
Dec 19, 2016
0
0
The hip fracture risk factors are generally similar among those with and without Alzheimer's disease, according to a recent study from the University of Eastern Finland. However, the incidence of hip fracture is higher among ...
Dec 7, 2016
0
1
Increased risk of fracture has been shown to be one of the complications arising from longstanding diabetes. With the worldwide increase in Type 2 Diabetes (T2D), in part due to aging populations, there is also increasing ...
Dec 1, 2016
0
11
Osteoporosis is preventable and treatable, but only a small proportion of people at risk for fractures are evaluated and treated, according to new osteoporosis guidelines written by an expert panel headed by Loyola Medicine ...
Nov 28, 2016
0
0
The use of benzodiazepines and related drugs increases the risk of hip fracture by 43% in persons with Alzheimer's disease, according to a new study from the University of Eastern Finland. The hip fracture risk was investigated ...
Nov 23, 2016
0
0
If you're in menopause before the age of 40, you have a higher fracture risk. That fact has already been proven by the Women's Health Initiative (WHI) clinical trials. Now a new study evaluating the same WHI data further ...
Nov 2, 2016
0
0
Abaloparatide, a selective activator of the parathyroid hormone receptor, has recently been shown to reduce fractures in postmenopausal women with osteoporosis.
Oct 19, 2016
0
0
